Structure Therapeutics GPCR
NASDAQ GPCR
$32.69 -2.38 (-6.77%)
At close: Sep 29, 2026 · 4:00 PM EDT

Structure Therapeutics (GPCR) Total Non-Current Liabilities (2022 - 2026)

Updated

Structure Therapeutics (GPCR) posted Total Non-Current Liabilities of $69.75 million for Q2 2026, up 58.4% from $44.05 million a year earlier and up 15.9% from the prior quarter.

Analysis

Structure Therapeutics (GPCR) Total Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Structure Therapeutics' Total Non-Current Liabilities came in at $66.89 million, up 75.2% from FY2024.

  • Annual Total Non-Current Liabilities shows a three-year compound annual growth rate of -32.0% (FY2022 to FY2025).
  • In prior years, Structure Therapeutics' Total Non-Current Liabilities was $38.19 million in FY2024 (+33.7%), $28.55 million in FY2023 (-86.6%) and $212.99 million in FY2022.
  • The Q2 2026 figure stands as the highest quarterly Total Non-Current Liabilities since Q4 2022.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last eight quarters, with growth averaging 58.0% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2025, with growth of 75.2%; the weakest was Q4 2023, with a decline of 86.6%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $60.17 million (Q1 2026), $66.89 million (Q4 2025) and $61.82 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Structure Therapeutics 7.49 Bn 7.49 Bn - 69.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 69.75 Mn
Mar 31, 2026 60.17 Mn
Dec 31, 2025 66.89 Mn
Sep 30, 2025 61.82 Mn
Jun 30, 2025 44.05 Mn
Mar 31, 2025 41.60 Mn
Dec 31, 2024 38.19 Mn
Sep 30, 2024 36.11 Mn
Jun 30, 2024 25.70 Mn
Mar 31, 2024 27.11 Mn
Dec 31, 2023 28.55 Mn
Sep 30, 2023 23.13 Mn
Dec 31, 2022 212.99 Mn
API Access

Structure Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=GPCR&period=max&api_key=YOUR_API_KEY